Trial Profile
Safety and anti-HCV efficacy of an IFN-free, sofosbuvir plus ribavirin therapy in HIV/HCV-coinfected patients after liver transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 04 Sep 2015 New trial record